ENDRA Life Sciences Inc. — Income Charts
18 quarters of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
Cost of Revenue
$0
Gross Profit
$0
R&D↓-43.6% -$885K
$1M
D&A↑+159.4% +$33K
$54K
Operating Income↓-23.3% -$615K
$-3M
EBITDA↑+159.4% +$33K
$54K
Interest Expense
$0
Other Income/Expense↑+99.7% +$770K
$-3K
Pretax Income↑+4.6% +$155K
$-3M
Tax Provision
$0
Net Income↑+4.6% +$155K
$-3M
Gross Margin
100.0%
Operating Margin
-45960.8%
Net Margin
-45761.3%
Effective Tax Rate↑+0.0pts
0.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+5.8pts
0.0%
ETR Foreign Differential (pp)
0.0%
Operating Lease Cost↑+3.8% +$1K
$30K
Revenue YoY Variation
-100.0%
Income YoY Variation↓-11.2pts
-23.3%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↑+1.0pts
-12.6%